Seikagaku (TSE:4548) Interest Expense : 円-4 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Seikagaku Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Seikagaku's interest expense for the three months ended in Dec. 2023 was 円 -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円-4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Seikagaku's Operating Income for the three months ended in Dec. 2023 was 円 848 Mil. Seikagaku's Interest Expense for the three months ended in Dec. 2023 was 円 -1 Mil. Seikagaku's Interest Coverage for the quarter that ended in Dec. 2023 was 848.00. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Seikagaku Interest Expense Historical Data

The historical data trend for Seikagaku's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku Interest Expense Chart

Seikagaku Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-22.00

-18.00

-16.00

-11.00

-5.00

Seikagaku Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-1.00	-1.00	-	-2.00	-1.00

Seikagaku Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-4 Mil.

Seikagaku (TSE:4548) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Seikagaku's Interest Expense for the three months ended in Dec. 2023 was 円-1 Mil. Its Operating Income for the three months ended in Dec. 2023 was 円848 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was 円59 Mil.

Seikagaku's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	848	/	-1
	=	848.00

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Seikagaku Corp has enough cash to cover all of its debt. Its financial situation is stable.

Seikagaku (TSE:4548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005

Website

http://www.seikagaku.co.jp

Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines